The present invention refers to oral compositions containing S- adenosyl methionine (or S-adenosyl-l-methionine or SAMe) in combination with at least one probiotic, at least one physiologically acceptable excipient and optionally at least one additional ingredient and use thereof in the treatment and/or prevention of mood disorders preferably in case of anxiety or depression.
展开▼